Wells Fargo’s Moderna MRNA Stock Holding History

Wells Fargo’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50,000	Closed	-$2.54M	–	7493
2026 Q1	$2.54M	Buy	+50,000	New	+$2.33M	﹤0.01%	3086
2023 Q2	–	Sell	-50,100	Closed	-$7.69M	–	7650
2023 Q1	$7.69M	Buy	50,100 +50,000	+50,000%	+$8.25M	﹤0.01%	1784
2022 Q4	$18K	Buy	+100	New	+$16.4K	﹤0.01%	5309
2022 Q3	–	Sell	-10,000	Closed	-$1.43M	–	7104
2022 Q2	$1.43M	Buy	10,000 +9,900	+9,900%	+$1.42M	﹤0.01%	3056
2022 Q1	$17K	Sell	100 -1,200	-92%	-$202K	﹤0.01%	6079
2021 Q4	$330K	Buy	+1,300	New	+$380K	﹤0.01%	4985
2021 Q3	–	Sell	-50,000	Closed	-$11.7M	–	7314
2021 Q2	$11.7M	Buy	+50,000	New	+$8.94M	﹤0.01%	2104
2021 Q1	–	Sell	-23,900	Closed	-$1.2M	–	7195
2020 Q4	$1.2M	Buy	+23,900	New	+$2.42M	﹤0.01%	3892

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Wells Fargo's MRNA Position: Q2 2026 in Review

Wells Fargo reduced its Moderna (MRNA) stake by 14% in Q2 2026, selling an estimated $1.07M and leaving 123,037 shares worth $8.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2327.

Wells Fargo first reported a position in MRNA in Q4 2018 and has held it in 31 quarters since. The position peaked at $220M in Q3 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Wells Fargo held 123,037 shares of Moderna worth $8.62M as of Q2 2026.
Wells Fargo sold 20,728 Moderna shares in Q2 2026, an estimated $1.07M.
Moderna made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #2327 holding.
Wells Fargo first reported a position in Moderna in Q4 2018 and has held it in 31 quarters since.
Wells Fargo's Moderna position peaked at $220M in Q3 2021.
783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.